The discovery could help scientists design new therapeutic agents to combat calcium overload of mitochondria in conditions ...

Alzheimer’s disease is one of the most well-known and widespread forms of dementia, affecting millions of people around the ...

Recent research progress into the molecular pathogenesis of Alzheimer's disease has been translated into several promising drug candidates that have the potential to produce disease-modifying effects.

Scientists Identify Key Enzyme in Alzheimer's Disease That Links Brain Inflammation to Memory Loss Apr. 14, 2025 — A research team has identified a previously unknown enzyme, SIRT2, that plays a ...

For a long time, many researchers believed that Alzheimer’s is caused by the build-up of a sticky protein called amyloid-beta ...

4, 2025 — Damage to the mitochondria, the 'power plants ... Highly Accurate Blood Test Diagnoses Alzheimer's Disease, Measures Extent of Dementia Mar. 31, 2025 — A newly developed blood ...

Alzheimer’s disease doesn’t arrive suddenly. Instead, it emerges slowly, beginning with subtle changes that might be dismissed as normal aging before progressing through increasingly serious ...

Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.

It is hypothesized that Dimebon acts on mitochondria to stabilize function ... effect regarding pathological changes in Alzheimer's disease. Speculation regarding mechanisms of action include ...